Previous 10 | Next 10 |
home / stock / bhc:cc / bhc:cc news
Bausch Health Companies ( NYSE: BHC ) said its travelers' diarrhea drug Xifaxan's patent protection is till July 24, 2029 and thus a tentatively approved generic version of the drug developed by Norwich Pharmaceuticals' is not expected to hit the U.S. market unti...
Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin PR Newswire LAVAL, QC , Sept. 9, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("the Company"), and its gastroenterology business Salix Pha...
Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations Canada NewsWire LAVAL, Quebec , Sept. 8, 2022 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) (the "Company") clarified today certain provisions rela...
The shares of Canadian pharma company Bausch Health ( NYSE: BHC ) fell ~10% on Thursday on above average volume after a federal register indicated tentative FDA approval for Rifaximin, a generic from Norwich Pharmaceuticals rivaling BHC’s Xifaxan. In July, a...
Summary ValueAct’s 13F portfolio value decreased from $7.27B to $6.27B this quarter. ValueAct increased TopBuild, Fiserv, KKR, and Insight Enterprises while reducing LKQ, Citigroup, and SLM Corp. The top three positions are Fiserv, KKR, and Seagate Technology, and they ...
What happened? Shares of Bausch Health Companies ( TSX:BHC )( NYSE:BHC ) have seen a sharp rally in the last month. After falling for seven months in a row, BHC stock jumped by 33.6% in August, posting its best monthly performance since November 2017. With this, Bausch Healt...
S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index and S&P/TSX 60 Index S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index and S&P/TSX 60 Index Canada NewsWire TORONTO , Sept. 2, 2022 /CN...
Bausch Health ( NYSE: BHC ) said it began offers to exchange certain existing senior notes for up to a total principal amount of $4B of new secured notes. The new secured notes consists of up to $2.5B of new 11.00% First Lien secured notes due 2028...
Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior Notes Canada NewsWire LAVAL, Quebec , Aug. 30, 2022 /CNW/ -- Bausch Health Companies Inc...
The S&P/TSX Composite Index fell 10 points on Tuesday, August 23. Canadian investors undoubtedly have a lot of questions on their mind, as this eventful summer winds to a close. Today, I want to focus on three things investors may want to watch for on the Toronto Stock Exchange (T...
News, Short Squeeze, Breakout and More Instantly...
Bausch Health Companies Inc. Company Name:
BHC:CC Stock Symbol:
TSXC Market:
Bausch Health Companies Inc. Website:
LAVAL, QC / ACCESSWIRE / July 24, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") has become aware of a news article issued by Reorg® today, citing unnamed sources. The article contains unsubstantiated rumors, including that the Company is considering a bankruptcy o...
LAVAL, QC / ACCESSWIRE / July 19, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the appointment of two new members to its Executive Leadership Team (ELT). Jean-Jacques Charhon ("JJ") will join the Company as Chief Financial Officer on August 19, 2024. JJ has over 25 ...
LAVAL, QC / ACCESSWIRE / July 11, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2024 financial results on Thursday, August 1, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business...